OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Release Date
2021
(4)
2024
(2)
2023
(2)
2025
(1)
2022
(1)
2019
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Phenotype delineation of ZNF462 related syndrome.
Not available
S-EPMC6935050
|
biostudies-literature
Cite
Accelarated immune ageing is associated with COVID-19 disease severity.
Not available
S-EPMC10782727
|
biostudies-literature
Cite
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue.
Not available
S-EPMC11362542
|
biostudies-literature
Cite
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Not available
S-EPMC8497028
|
biostudies-literature
Cite
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.
Not available
S-EPMC8169555
|
biostudies-literature
Cite
Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
Not available
S-EPMC10391361
|
biostudies-literature
Cite
Ventilation strategies and risk factors for intraoperative respiratory critical events and postoperative pulmonary complications in neonates and small infants: a secondary analysis of the NECTARINE cohort<sup>☆</sup>.
Not available
S-EPMC12597469
|
biostudies-literature
Cite
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Not available
S-EPMC7723445
|
biostudies-literature
Cite
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Not available
S-EPMC7894131
|
biostudies-literature
Cite
Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment.
Not available
S-EPMC9616982
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets